Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112


Genomic medicine and lung diseases.

Center DM, Schwartz DA, Solway J, Gail D, Laposky AD, Lin QS, Gan W.

Am J Respir Crit Care Med. 2012 Aug 1;186(3):280-5. doi: 10.1164/rccm.201203-0569WS. Epub 2012 May 31. Review.


Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research.

Punturieri A, Szabo E, Croxton TL, Shapiro SD, Dubinett SM.

J Natl Cancer Inst. 2009 Apr 15;101(8):554-9. doi: 10.1093/jnci/djp023. Epub 2009 Apr 7.


Getting from genes to function in lung disease: a National Heart, Lung, and Blood Institute workshop report.

Ober C, Butte AJ, Elias JA, Lusis AJ, Gan W, Banks-Schlegel S, Schwartz D.

Am J Respir Crit Care Med. 2010 Sep 15;182(6):732-7. doi: 10.1164/rccm.201002-0180PP. Epub 2010 Jun 17.


Integrating genomic and clinical medicine: searching for susceptibility genes in complex lung diseases.

Desai AA, Hysi P, Garcia JG.

Transl Res. 2008 Apr;151(4):181-93. doi: 10.1016/j.trsl.2007.10.005. Epub 2007 Dec 18. Review.


[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.


Report of a National Heart, Lung, And Blood Institute Workshop: heterogeneity in cardiometabolic risk in Asian Americans In the U.S. Opportunities for research.

Narayan KM, Aviles-Santa L, Oza-Frank R, Pandey M, Curb JD, McNeely M, Araneta MR, Palaniappan L, Rajpathak S, Barrett-Connor E; Cardiovascular Disease in Asian and Pacific Islander Populations NHLBI Working Group.

J Am Coll Cardiol. 2010 Mar 9;55(10):966-73. doi: 10.1016/j.jacc.2009.07.075.


National Heart, Lung, and Blood Institute and the translation of cardiovascular discoveries into therapeutic approaches.

Galis ZS, Black JB, Skarlatos SI.

Circ Res. 2013 Apr 26;112(9):1212-8. doi: 10.1161/CIRCRESAHA.113.301100.


Cardiovascular genomics, personalized medicine, and the National Heart, Lung, and Blood Institute: part I: the beginning of an era.

O'Donnell CJ, Nabel EG.

Circ Cardiovasc Genet. 2008 Oct;1(1):51-7. doi: 10.1161/CIRCGENETICS.108.813337. Review.


Malfolded protein structure and proteostasis in lung diseases.

Balch WE, Sznajder JI, Budinger S, Finley D, Laposky AD, Cuervo AM, Benjamin IJ, Barreiro E, Morimoto RI, Postow L, Weissman AM, Gail D, Banks-Schlegel S, Croxton T, Gan W.

Am J Respir Crit Care Med. 2014 Jan 1;189(1):96-103. doi: 10.1164/rccm.201306-1164WS.


Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.

Lieberman R, Nelson WG, Sakr WA, Meyskens FL Jr, Klein EA, Wilding G, Partin AW, Lee JJ, Lippman SM.

Urology. 2001 Apr;57(4 Suppl 1):4-27.


Genomic medicine in Mexico: initial steps and the road ahead.

Jimenez-Sanchez G, Silva-Zolezzi I, Hidalgo A, March S.

Genome Res. 2008 Aug;18(8):1191-8. doi: 10.1101/gr.065359.107.


Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.

Ganesh SK, Skelding KA, Mehta L, O'Neill K, Joo J, Zheng G, Goldstein J, Simari R, Billings E, Geller NL, Holmes D, O'Neill WW, Nabel EG.

Pharmacogenomics. 2004 Oct;5(7):952-1004.


Will genomics widen or help heal the schism between medicine and public health?

Khoury MJ, Gwinn M, Burke W, Bowen S, Zimmern R.

Am J Prev Med. 2007 Oct;33(4):310-7.


Atherosclerosis: the path from genomics to therapeutics.

Miller DT, Ridker PM, Libby P, Kwiatkowski DJ.

J Am Coll Cardiol. 2007 Apr 17;49(15):1589-99. Epub 2007 Apr 2. Review.


Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.

Douglas PS, Taylor A, Bild D, Bonow R, Greenland P, Lauer M, Peacock F, Udelson J.

Circ Cardiovasc Imaging. 2009 Jul;2(4):339-48. doi: 10.1161/CIRCIMAGING.108.123999.


Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.

De Gruttola VG, Clax P, DeMets DL, Downing GJ, Ellenberg SS, Friedman L, Gail MH, Prentice R, Wittes J, Zeger SL.

Control Clin Trials. 2001 Oct;22(5):485-502.


Evolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genes.

Kass DJ, Kaminski N.

Clin Transl Sci. 2011 Oct;4(5):372-9. doi: 10.1111/j.1752-8062.2011.00287.x. Review.


Leading the way to genomic medicine.

Manolio TA, Green ED.

Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):1-7. doi: 10.1002/ajmg.c.31384. Epub 2014 Mar 11.


Supplemental Content

Support Center